Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 318 (ZNF318) is a large human protein encoded by the ZNF318 gene on chromosome 6 and belongs to the zinc finger protein family, which is characterized by DNA-binding zinc finger domains. ZNF318 is predicted to have protein heterodimerization and homodimerization activities and is involved in both the positive and negative regulation of transcription from DNA templates. It is localized in the cytosol and nucleoplasm. Recent functional studies show that ZNF318, also called testicular zinc finger protein (TZF), exists in alternatively spliced forms that fine-tune androgen receptor (AR) signaling: one isoform functions as a corepressor of AR, while the other acts as a coactivator. The protein is especially notable in the context of reproductive biology, modulating AR-mediated transcriptional response during spermatogenesis and meiotic division. ZNF318 is not currently implicated as a classic therapeutic target, nor have drugs been developed to modulate its function.
Not applicable. No known drugs target ZNF318.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 318 (ZNF318).